• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CSTP1 通过靶向 Akt/FoxO3a 信号通路抑制膀胱癌细胞中的 IL-6 表达。

CSTP1 inhibits IL-6 expression through targeting Akt/FoxO3a signaling pathway in bladder cancer cells.

机构信息

The Central Laboratory of Sanming First Hospital Affiliated to Fujian Medical University, Sanming City, 365000, China.

Department of Clinical Medical Oncology, Qingyuan People's Hospital, The Six Affiliated Hosptial of Guangzhou Medical University, Qingyuan City, 511518, China.

出版信息

Exp Cell Res. 2019 Jul 1;380(1):80-89. doi: 10.1016/j.yexcr.2019.04.019. Epub 2019 Apr 16.

DOI:10.1016/j.yexcr.2019.04.019
PMID:31002815
Abstract

CSTP1, a recently identified protein phosphotase, is frequently repressed in bladder cancers. Previous results showed that CSTP1 over-expression inhibited cell cycle progression and promoted apoptosis through dephosphorylating Akt kinase at Ser473 site in bladder cancer cells, but the mechanisms how CSTP1 exerted tumor suppressive activity remains unclear. In this study, we analyzed the gene expression profile changes that affected by CSTP1 overexpression by microarray, and reported that CSTP1 decreased IL-6 expression/secretion in bladder cancer cells and re-expression of IL-6 abrogated CSTP1's tumor suppressive activity. We also found that FoxO3a occupy IL-6 gene promoter and repressed IL mRNA transcription. Further results showed that decreased expression of IL-6 in CSTP1-overexpressing cells inactivated Stat3 transcriptional factor, which resulted in the down-regulation of cyclin D1, Bcl-xl expression. Spearman correlation analysis revealed that the mRNA level of CSTP1 correlated inversely with that of IL-6 in bladder cancer tissues. In conclusion, our studies revealed that protein phosphotase CSTP1 inhibited IL-6 expression through targeting Akt/FoxO3a signaling pathway and IL-6 inactivated Stat3 was necessary for CSTP1's tumor suppressive function.

摘要

CSTP1 是一种新鉴定的蛋白磷酸酶,在膀胱癌中经常受到抑制。先前的研究结果表明,CSTP1 过表达通过使膀胱癌细胞中 Akt 激酶在 Ser473 位点去磷酸化来抑制细胞周期进程并促进细胞凋亡,但 CSTP1 发挥肿瘤抑制活性的机制尚不清楚。在这项研究中,我们通过微阵列分析了受 CSTP1 过表达影响的基因表达谱变化,并报告 CSTP1 降低了膀胱癌细胞中 IL-6 的表达/分泌,并且重新表达 IL-6 可消除 CSTP1 的肿瘤抑制活性。我们还发现 FoxO3a 占据了 IL-6 基因启动子并抑制了 IL mRNA 的转录。进一步的结果表明,在 CSTP1 过表达细胞中 IL-6 的表达降低使 Stat3 转录因子失活,从而导致细胞周期蛋白 D1、Bcl-xl 表达下调。Spearman 相关分析显示,膀胱癌细胞中 CSTP1 的 mRNA 水平与 IL-6 的 mRNA 水平呈负相关。总之,我们的研究表明,蛋白磷酸酶 CSTP1 通过靶向 Akt/FoxO3a 信号通路抑制 IL-6 的表达,而 IL-6 使 Stat3 失活是 CSTP1 肿瘤抑制功能所必需的。

相似文献

1
CSTP1 inhibits IL-6 expression through targeting Akt/FoxO3a signaling pathway in bladder cancer cells.CSTP1 通过靶向 Akt/FoxO3a 信号通路抑制膀胱癌细胞中的 IL-6 表达。
Exp Cell Res. 2019 Jul 1;380(1):80-89. doi: 10.1016/j.yexcr.2019.04.019. Epub 2019 Apr 16.
2
CSTP1, a novel protein phosphatase, blocks cell cycle, promotes cell apoptosis, and suppresses tumor growth of bladder cancer by directly dephosphorylating Akt at Ser473 site.CSTP1,一种新型的蛋白磷酸酶,通过直接将 Akt 丝氨酸 473 位点去磷酸化来阻滞细胞周期、促进细胞凋亡、抑制膀胱癌肿瘤生长。
PLoS One. 2013 Jun 17;8(6):e65679. doi: 10.1371/journal.pone.0065679. Print 2013.
3
MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.微小RNA-608通过AKT/FOXO3a信号通路抑制膀胱癌的增殖。
Mol Cancer. 2017 May 26;16(1):96. doi: 10.1186/s12943-017-0664-1.
4
PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.PAX3通过调节甲状腺癌中主要信号通路和转录因子FOXO3a的活性,是一种新型肿瘤抑制因子。
Oncotarget. 2016 Aug 23;7(34):54744-54757. doi: 10.18632/oncotarget.10753.
5
DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression.DANCR 通过增强 IL-11-STAT3 信号通路和 CCND1 表达促进膀胱癌的转移和增殖。
Mol Ther. 2019 Feb 6;27(2):326-341. doi: 10.1016/j.ymthe.2018.12.015. Epub 2019 Jan 9.
6
4-Chlorobenzoyl berbamine, a novel berbamine derivative, induces apoptosis in multiple myeloma cells through the IL-6 signal transduction pathway and increases FOXO3a-Bim expression.4-氯苯甲酰基小檗胺,一种新型小檗胺衍生物,通过 IL-6 信号转导通路诱导多发性骨髓瘤细胞凋亡,并增加 FOXO3a-Bim 的表达。
Oncol Rep. 2013 Jul;30(1):425-32. doi: 10.3892/or.2013.2431. Epub 2013 Apr 26.
7
CHP2 Promotes Cell Proliferation in Breast Cancer via Suppression of FOXO3a.CHP2 通过抑制 FOXO3a 促进乳腺癌细胞增殖。
Mol Cancer Res. 2018 Oct;16(10):1512-1522. doi: 10.1158/1541-7786.MCR-18-0157. Epub 2018 Jul 2.
8
Cytosolic and mitochondrial ROS production resulted in apoptosis induction in breast cancer cells treated with Crocin: The role of FOXO3a, PTEN and AKT signaling.西红花苷处理的乳腺癌细胞中细胞溶质和线粒体 ROS 的产生导致细胞凋亡:FOXO3a、PTEN 和 AKT 信号的作用。
Biochem Pharmacol. 2020 Jul;177:113999. doi: 10.1016/j.bcp.2020.113999. Epub 2020 Apr 28.
9
Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis.谷氨酰胺通过 ROS 和谷氨酰胺分解激活 STAT3 影响 T24 膀胱癌细胞增殖。
Int J Mol Med. 2019 Dec;44(6):2189-2200. doi: 10.3892/ijmm.2019.4385. Epub 2019 Oct 25.
10
The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway.抑癌基因 Nkx2.8 通过上调 FOXO3a 并抑制 MEK/ERK 信号通路抑制膀胱癌增殖。
Carcinogenesis. 2012 Mar;33(3):678-86. doi: 10.1093/carcin/bgr321. Epub 2012 Jan 4.

引用本文的文献

1
miR-944 inhibits malignant progression of bladder cancer through ATIC/AKT/FOXO3 A axis mediated by SHMT1.微小RNA-944通过丝氨酸羟甲基转移酶1介导的ATIC/AKT/FOXO3A轴抑制膀胱癌的恶性进展。
In Vitro Cell Dev Biol Anim. 2025 May 29. doi: 10.1007/s11626-025-01050-1.
2
A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer.中性粒细胞胞外诱捕网相关分类可预测结肠癌的预后和免疫治疗反应。
Sci Rep. 2023 Nov 7;13(1):19297. doi: 10.1038/s41598-023-45558-6.
3
Knockdown of ZNF280A inhibits cell proliferation and promotes cell apoptosis of bladder cancer.
敲低 ZNF280A 抑制膀胱癌细胞增殖并促进细胞凋亡。
Histol Histopathol. 2024 Mar;39(3):367-379. doi: 10.14670/HH-18-640. Epub 2023 Jun 13.
4
Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations.差异离子迁移质谱免疫肽组学鉴定携带结直肠癌驱动突变的新抗原。
Commun Biol. 2022 Aug 18;5(1):831. doi: 10.1038/s42003-022-03807-w.
5
FOXO3A Expression in Upper Tract Urothelial Carcinoma.FOXO3A在上尿路尿路上皮癌中的表达
Front Oncol. 2021 Apr 20;11:603681. doi: 10.3389/fonc.2021.603681. eCollection 2021.
6
CPPED1-targeting microRNA-371a-5p expression in human placenta associates with spontaneous delivery.CPPED1 靶向的 microRNA-371a-5p 在人胎盘组织中的表达与自发性分娩相关。
PLoS One. 2020 Jun 10;15(6):e0234403. doi: 10.1371/journal.pone.0234403. eCollection 2020.
7
Desloratadine, a Novel Antigrowth Reagent for Bladder Cancer.地氯雷他定,膀胱癌新型抗增殖剂。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820926591. doi: 10.1177/1533033820926591.
8
Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.华蟾酥毒基通过抑制IL-6-骨桥蛋白-STAT3信号通路抑制骨肉瘤癌细胞的特性。
Drug Des Devel Ther. 2019 Dec 4;13:4075-4090. doi: 10.2147/DDDT.S224312. eCollection 2019.